Bactericidal activity in vitro of various rifamycins against Mycobacterium avium and Mycobacterium tuberculosis
about
Daily dosing of rifapentine cures tuberculosis in three months or less in the murine modelChemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex infection induced in miceIn vivo activities of newer rifamycin analogs against Mycobacterium avium infectionIn vitro antimycobacterial activities of newly synthesized benzoxazinorifamycinsAnalysis of rifapentine for preventive therapy in the Cornell mouse model of latent tuberculosisEvaluation of once-weekly therapy for tuberculosis using isoniazid plus rifamycins in the mouse aerosol infection modelDevelopment of rifapentine susceptibility tests for Mycobacterium tuberculosisComparative in vivo activities of rifabutin and rifapentine against Mycobacterium avium complexIn vitro antimicrobial activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex, determined by the radiometric methodComparison of activities of rifapentine and rifampin against Mycobacterium tuberculosis residing in human macrophagesBacteriostatic and bactericidal activities of benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium in human macrophagesSusceptibility testing of Mycobacterium avium complex isolatesLow-dose aerosol infection model for testing drugs for efficacy against Mycobacterium tuberculosisContribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosisPharmacokinetics of rifapentine in subjects seropositive for the human immunodeficiency virus: a phase I study.Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.In vitro activities of aminoglycosides, lincosamides, and rifamycins against Mycobacterium leprae.Population pharmacokinetics of rifapentine and desacetyl rifapentine in healthy volunteers: nonlinearities in clearance and bioavailabilityMulticenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media.Single-dose intrapulmonary pharmacokinetics of rifapentine in normal subjects.Effects of four different meal types on the population pharmacokinetics of single-dose rifapentine in healthy male volunteers.Protein binding of rifapentine and its 25-desacetyl metabolite in patients with pulmonary tuberculosis.An update on the use of rifapentine for tuberculosis therapy.Beige mouse model for Mycobacterium avium complex disease.Drug-resistant tuberculosis: emerging treatment options.Current development and future prospects in chemotherapy of tuberculosisPotent twice-weekly rifapentine-containing regimens in murine tuberculosis.In vitro activities of new macrolides and rifapentine against Brucella spp.A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary TuberculosisRifapentine for the treatment of pulmonary tuberculosis.Pharmacokinetics of rifapentine in patients with varying degrees of hepatic dysfunction.Repeated administration of high-dose intermittent rifapentine reduces rifapentine and moxifloxacin plasma concentrations.New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development.Developing pyrrole-derived antimycobacterial agents: a rational lead optimization approach.Challenges and opportunities in developing novel drugs for TB.New treatment options for multidrug-resistant tuberculosis.Rifampin vs. rifapentine: what is the preferred rifamycin for tuberculosis?Rapid determination of rifampin resistance in clinical isolates of Mycobacterium tuberculosis by real-time PCR.Moxifloxacin population pharmacokinetics in patients with pulmonary tuberculosis and the effect of intermittent high-dose rifapentine.Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice.
P2860
Q21144660-6CC5E259-B399-486C-9C14-40736FC58776Q28320238-C8D110DD-7930-45D6-86D4-0270B309A87AQ28322002-02AE8D98-E78E-44C5-8A83-D16E22391C78Q28327994-872A36B6-B6FB-43C0-A02A-A7EDF84DFF72Q28343546-BE7EFEE3-4250-46A6-9316-6FF40BE2AED1Q28369170-433E231E-B8A2-444E-ADC9-4C827AC5F278Q28369453-0D36A0E6-63E8-4D9E-BC2C-173976E2BCD6Q28369712-3F72985A-2B67-4DA4-A3BA-C4CDACBEBCD1Q28378656-432B7AF5-D007-45E2-90AB-7E57AEA49983Q28378747-69DCA339-F0A4-4F6C-A05C-2241E820FB57Q28379003-71C3CA5F-03C0-44A3-8D06-AF1D956785B6Q28379189-D6805059-1144-4DCE-A3F7-C4893DE49D79Q28379615-A94983C7-DDE6-4C44-8B74-2182C72C2BA0Q28379624-4965D94F-899F-4604-916C-6CD00FCFF1ADQ33178187-009655B4-FFD2-493D-9624-24C6AFC6E23DQ33735589-4B19D398-4D31-4F13-8D72-B1DC8483C95BQ33744463-291D8BC3-C075-4844-AE12-8CF76876A6FEQ33798061-20294DFC-BAA2-4A75-AD42-19259C3CDC43Q33962909-9D4E041C-2CAF-4823-BBE4-7D02E127526EQ33979162-80850699-EA20-4D00-A36D-156605C8E7D3Q34045240-90D0C174-D8AC-494D-A7B7-420504DAA7C1Q34058356-DE150089-F3CF-4EF4-94D6-191859ACE658Q35084363-195E9435-9CB1-4020-9DB6-6ABFC6DE0292Q35116742-6AE896C4-2801-4BED-816E-7B4D8E9A6ECDQ35683967-7C9016F2-05BF-4379-B3A8-8BEFF5E82673Q35705874-352BB815-B858-40A4-8C81-EF895EAB65B2Q35776635-07E87458-5857-4D01-8FE3-649B7840BEE6Q35812997-F610AB8B-F088-465D-9BFD-910C8A3B2C4CQ36012300-5F42E6AF-0141-49D3-BBDC-633946C110DFQ36643657-D1986B2E-2678-4035-B342-ECE7216AFCEAQ36897388-840FE442-046C-49F7-8F60-29D49DA4314DQ36949454-E4497114-CA97-4208-BDD4-1E06D0E0F3D5Q37346929-1B874B80-9AC6-42F3-82B1-8EBD6DAA24B2Q37845798-22A59EF9-D48B-4D15-90E1-C7A4EC6EB9D6Q37924294-624DE52F-1F50-4A20-AE84-F19F40AD8CF9Q38024041-C199EB88-389B-4DFF-B001-AB495BDDEF02Q40095703-DB4DEBC5-6783-401B-87DB-7AA2837C07A1Q40709027-6E978FD7-683D-4ACB-9F76-983A98B0D79EQ41962727-4D842003-4551-4B9A-8180-0A488AA8B969Q42286897-0B173BE4-1B4B-4BBA-B9EF-2504397435F3
P2860
Bactericidal activity in vitro of various rifamycins against Mycobacterium avium and Mycobacterium tuberculosis
description
1990 nî lūn-bûn
@nan
1990 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի մարտին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Bactericidal activity in vitro ...... and Mycobacterium tuberculosis
@ast
Bactericidal activity in vitro ...... and Mycobacterium tuberculosis
@en
Bactericidal activity in vitro ...... and Mycobacterium tuberculosis
@nl
type
label
Bactericidal activity in vitro ...... and Mycobacterium tuberculosis
@ast
Bactericidal activity in vitro ...... and Mycobacterium tuberculosis
@en
Bactericidal activity in vitro ...... and Mycobacterium tuberculosis
@nl
prefLabel
Bactericidal activity in vitro ...... and Mycobacterium tuberculosis
@ast
Bactericidal activity in vitro ...... and Mycobacterium tuberculosis
@en
Bactericidal activity in vitro ...... and Mycobacterium tuberculosis
@nl
P2093
P2860
P3181
P356
P1476
Bactericidal activity in vitro ...... and Mycobacterium tuberculosis
@en
P2093
L B Heifets
P J Lindholm-Levy
P2860
P304
P3181
P356
10.1164/AJRCCM/141.3.626
P407
P577
1990-03-01T00:00:00Z